IB20-03

Main Content

Donor socioeconomic status as a predictor of altered immune function and treatment response following hematopoietic cell transplantation for hematologic malignancy.

Study #: IB20-03

Study Status: Published

Presentation(s)

2021, ASH (Oral)

2022, Tandem (Oral)

2023, ASCO (Oral)

2024, ASPO (Oral)

The health risk of social disadvantage is transplantable into a new host.

Citation

Turcotte LM, Wang T, Beyer KM, Cole SW, Spellman SR, Allbee-Johnson M, Williams E, Zhou Y, Verneris MR, Rizzo JD, Knight JM.

Proceedings of the National Academy of Sciences of the United States of America. 2024, Jul 23: 121(30): 121(30):e2404108121. doi: 10.1073/pnas.2404108121. Epub 2024, Jul 15. PMCID:PMC11287259.

PubMed

PMID: 39008669

Abstract